Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jurgen Heymann

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Kidney International|June 23, 2022
Impact of APOL1 kidney risk variants on glomerular transcriptomesJeffrey B Kopp, Jurgen Heymann
The Journal of Clinical Investigation|April 3, 2019
c-Src is in the effector pathway linking uPAR and podocyte injuryJeffrey B Kopp, Jurgen Heymann
Seminars in Nephrology|November 8, 2017
APOL1 Renal Risk Variants: Fertile Soil for HIV-Associated NephropathyJeffrey B Kopp, Jurgen Heymann, Cheryl A Winkler
Frontiers in Medicine|November 12, 2021
Lessons From APOL1 Animal ModelsTeruhiko Yoshida, Khun Zaw Latt, Jurgen Heymann, et al.
Frontiers in Medicine|November 15, 2021
Glomerular Kidney Diseases in the Single-Cell EraKhun Zaw Latt, Jurgen Heymann, Teruhiko Yoshida, et al.
BMC Nephrology|July 15, 2020
Macrophage polarization in innate immune responses contributing to pathogenesis of chronic kidney diseaseHewang Lee, Michael B Fessler, Peng Qu, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 10, 2017
Therapeutics for APOL1 nephropathies: putting out the fire in the podocyteJurgen Heymann, Cheryl A Winkler, Maarten Hoek, et al.
BMC Nephrology|August 29, 2020
APOL1 renal risk variants exacerbate podocyte injury by increasing inflammatory stressHidefumi Wakashin, Jurgen Heymann, Hila Roshanravan, et al.
Seminars in Nephrology|July 29, 2015
APOL1 Kidney Disease Risk Variants: An Evolving LandscapePatrick D Dummer, Sophie Limou, Avi Z Rosenberg, et al.
Kidney International Reports|January 16, 2023
Transcriptomic Analysis of Human Podocytes <i>In Vitro</i>: Effects of Differentiation and <i>APOL1</i> GenotypeTeruhiko Yoshida, Khun Zaw Latt, Avi Z Rosenberg, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Kidney International|June 23, 2022
Impact of APOL1 kidney risk variants on glomerular transcriptomesJeffrey B Kopp, Jurgen Heymann
The Journal of Clinical Investigation|April 3, 2019
c-Src is in the effector pathway linking uPAR and podocyte injuryJeffrey B Kopp, Jurgen Heymann
Seminars in Nephrology|November 8, 2017
APOL1 Renal Risk Variants: Fertile Soil for HIV-Associated NephropathyJeffrey B Kopp, Jurgen Heymann, Cheryl A Winkler
Frontiers in Medicine|November 12, 2021
Lessons From APOL1 Animal ModelsTeruhiko Yoshida, Khun Zaw Latt, Jurgen Heymann, et al.
Frontiers in Medicine|November 15, 2021
Glomerular Kidney Diseases in the Single-Cell EraKhun Zaw Latt, Jurgen Heymann, Teruhiko Yoshida, et al.
BMC Nephrology|July 15, 2020
Macrophage polarization in innate immune responses contributing to pathogenesis of chronic kidney diseaseHewang Lee, Michael B Fessler, Peng Qu, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 10, 2017
Therapeutics for APOL1 nephropathies: putting out the fire in the podocyteJurgen Heymann, Cheryl A Winkler, Maarten Hoek, et al.
BMC Nephrology|August 29, 2020
APOL1 renal risk variants exacerbate podocyte injury by increasing inflammatory stressHidefumi Wakashin, Jurgen Heymann, Hila Roshanravan, et al.
Seminars in Nephrology|July 29, 2015
APOL1 Kidney Disease Risk Variants: An Evolving LandscapePatrick D Dummer, Sophie Limou, Avi Z Rosenberg, et al.
Kidney International Reports|January 16, 2023
Transcriptomic Analysis of Human Podocytes <i>In Vitro</i>: Effects of Differentiation and <i>APOL1</i> GenotypeTeruhiko Yoshida, Khun Zaw Latt, Avi Z Rosenberg, et al.
Pageof 2